Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
Applied Optics|May 20, 1997
Accuracy and precision of single-pulse one-dimensional vibrational coherent anti-Stokes Raman-scattering temperature measurementsJ Jonuscheit, A Thumann, M Schenk, et al.
Clinical and Experimental Immunology|December 2, 2008
Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cellsK E Odening, W Li, R Rutz, et al.
Blood|June 15, 1995
Sustained long-term hematopoiesis after myeloablative therapy with peripheral blood progenitor cell supportR Haas, B Witt, R Möhle, et al.
The Review of Scientific Instruments|January 5, 2011
Characterization of a fast gas analyzer based on Raman scattering for the analysis of synthesis gasS C Eichmann, M Weschta, J Kiefer, et al.
Gene Therapy|October 30, 2009
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K)P Maier, I Spier, S Laufs, et al.
Bone Marrow Transplantation|August 10, 2000
Human multidrug resistance-1 gene transfer to long-term repopulating human mobilized peripheral blood progenitor cellsB Schiedlmeier, K Wermann, K Kühlcke, et al.
Cytotherapy|December 7, 2006
Retroviral MDR1 gene transfer into marrow-engrafting human peripheral blood progenitor cells results in preferential transgene expression in the immature myeloid compartment rather than in mature myeloid progeny in vivoE C Buss, S Laufs, S Naundorf, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.
Journal of Medicinal Chemistry|October 1, 1990
An initial three-component pharmacophore for specific serotonin-3 receptor ligandsJ P Rizzi, A A Nagel, T Rosen, et al.
British Journal of Haematology|June 20, 1998
The dose of granulocyte colony-stimulating factor administered following cytotoxic chemotherapy is not related to the rebound level of circulating CD34+ haemopoietic progenitor cells during marrow recoveryS Martin-Murea, M T Voso, S Hohaus, et al.
Pageof 10